Last reviewed · How we verify
NatrOVA Creme Rinse - 1%
At a glance
| Generic name | NatrOVA Creme Rinse - 1% |
|---|---|
| Sponsor | ParaPRO LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse (PHASE2)
- NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers (PHASE1)
- A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age (PHASE1)
- Phototoxicity Potential of NatrOVA Creme Rinse - 1% (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NatrOVA Creme Rinse - 1% CI brief — competitive landscape report
- NatrOVA Creme Rinse - 1% updates RSS · CI watch RSS
- ParaPRO LLC portfolio CI